ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ACPA"

  • Abstract Number: 836 • 2017 ACR/ARHP Annual Meeting

    B Cell Receptor Sequencing of Anti-Citrullinated Protein Antibody Expressing B Cells Indicates a Selective Advantage for the Introduction of N-Glycosylation Sites during Somatic Hypermutation

    Rochelle D. Vergroesen1, Linda Slot1, Lise Hafkenscheid1, Marvyn T. Koning2, Ellen I.H. van der Voort3, Christine A. Grooff1, George Zervakis2, Tom W.J. Huizinga1, Theo Rispens4, Hendrik Veelken2, Rene E.M. Toes1 and Hans U. Scherer3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Hematology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Immunopathology, Sanquin Research, Amsterdam, Netherlands

    Background/Purpose: The vast majority (>90%) of anti-citrullinated protein antibodies (ACPA) of the IgG isotype in serum and synovial fluid of patients with rheumatoid arthritis carry…
  • Abstract Number: 970 • 2017 ACR/ARHP Annual Meeting

    ACPA Activate Challenged Synovial Fibroblasts through a PAD Dependent Mechanism: A Potential Explanation of the “Second Hit Model” in RA

    Meng Sun1, Vijay Joshua1, Akilan Krishnamurthy1, Aase Hensvold1, Yanying Liu2, Sergiu-Bogdan Catrina3, Caroline Ospelt4, Vivianne Malmström1, Johanna Steen1, Marianne Engström1, Heidi Wähämaa1, Bence Rethi1 and Anca I. Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Peking University People's Hospital, Beijing, China, 3Molecular Medicine and Surgery, Molecular Medicine and Surgery, Stockholm, Sweden, 4Center of Experimental Rheumatology, University Hospital Zürich, Zurich, Switzerland

    Background/Purpose: Anti-citrullinated proteins antibodies (ACPAs) injected in mice induce IL-8 dependent bone loss and arthralgia, but no synovial changes. We hypothesized that additional stimulus, sensitizing…
  • Abstract Number: 990 • 2017 ACR/ARHP Annual Meeting

    Higher Omega-6 to Omega-3 Fatty Acid Ratio Is Associated with Increased Odds of Inflammatory Arthritis in a Health Fair Population Positive for Anti-Citrullinated Protein Antibodies (ACPA)

    Kristen J. Polinski1, Ryan W. Gan2, Elizabeth A. Bemis1, M. Kristen Demoruelle3, Michael J. Clare-Salzler4, V. Michael Holers5, Kevin D. Deane6 and Jill M. Norris7, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Colorado School of Public Health, University of Colorado Denver, Aurora, CO, 31775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, 4Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, 5Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 6Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 7Department of Epidemiology, Colorado School of Public Health, Aurora, CO

    Background/Purpose: We previously found that lower levels of omega-3 fatty acids (n-3 FA) were associated with the presence of inflammatory arthritis (IA) as well as…
  • Abstract Number: 583 • 2016 ACR/ARHP Annual Meeting

    Associations of Serum Anti-Citrullinated Proteins and Cytokines with Radiographic Scores in African-American Rheumatoid Arthritis Patients

    Dongmei Sun1, William H Robinson2, Xiangqin Cui3, Vincent A. Laufer4, Maria I. Danila5, Richard J. Reynolds6, Chander Raman7, Stephanie Ledbetter8, Alexander Szalai9 and S. Louis Bridges Jr.9, 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Rheumatology and Immunology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham, AL, 6Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Medicine/Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 81825 University Blvd., University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Serum anti-citrullinated proteins (ACPA, including anti-CCP antibodies) and rheumatoid factor (RF) are critical diagnostic markers for RA, and are associated with more severe radiographic…
  • Abstract Number: 2612 • 2016 ACR/ARHP Annual Meeting

    Sero-Positivity for Rheumatoid Factor Is an Independent Predictor for Achievement of Good EULAR Response at 24 Weeks in ACPA Positive Rheumatoid Arthritis Patients Treated with Abatacept: Results from Japanese Multicenter Registry

    Nobunori Takahashi1, Toshihisa Kojima1, Shuji Asai1 and Naoki Ishiguro2, 1Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, 2Nagoya University, Nagoya, Japan

    Background/Purpose: Abatacept is a new class of biologic agent for the treatment of rheumatoid arthritis (RA) that inhibits T cell activation by binding to CD80/86.…
  • Abstract Number: 584 • 2016 ACR/ARHP Annual Meeting

    Glycoprotein VI: A Potential Target for ACPA-Mediated Platelet Activation?

    John Stack1, Anne Madigan2, Laura Helbert1, Niamh Redmond1, Eimear Dunne3, Dermot Kenny3 and Geraldine M. McCarthy2, 1Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, 2Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, 3Molecular and Cellular Therapeutics, RCSI, Dublin 2, Ireland

    Background/Purpose: Arterial thrombosis is a major cause of mortality in  rheumatoid arthritis (RA),especially in anti-citrullinated protein antibody (ACPA)-positive patients Recent studies suggest that platelet activation…
  • Abstract Number: 2613 • 2016 ACR/ARHP Annual Meeting

    Seropositivity for RF or ACPA Predicts Long Term Drug Retention with Rituximab, but Not with Abatacept and Tocilizumab : Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis

    Jacques-Eric Gottenberg1, Jacques Morel2, Arnaud Constantin3, Thomas Bardin4, Alain G. Cantagrel5, Bernard Combe6, Maxime Dougados7, Rene-Marc Flipo8, Alain Saraux9, Thierry Schaeverbeke10, Jean Sibilia11, Martin Soubrier12, Olivier Vittecoq13, Elodie Perrodeau14, Philippe Ravaud15, Xavier Mariette16 and on behalf of the French Society of Rheumatology and of all the investigators participating to the AIR, ORA and REGATE registries, 1Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 2Rheumatology, Department of Rheumatology, Montpellier University Hospital, Montpellier, France, 3Rheumatology, CHU Purpan - Hopital Pierre-Paul Riquet, Toulouse, France, 4Clinique de Rhumatologie, Hopital Lariboisiere, Paris Cedex 10, France, 5Rheumatology, Centre Hospitalier Universitaire, Toulouse Purpan, Toulouse, France, 6Département Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 7Rheumatology, Paris Descartes University, Paris, France, 8Rheumatology, University Hospital, Lille, France, 9Rheumatology, Brest University Hospital, Brest, France, 10Rheumatology, CHU Bordeaux, Bordeaux, France, 11Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 12Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 13Rheumatology, Rouen University Hospital &INSERM U905, Rouen, France, 14Epidemiology, Hopital Hotel Dieu, Paris Descartes University, Paris, France, 15Epidemiologist, PARIS, France, 16Rheumatology, Rheumatology department, Bicetre Hospital, Paris-Sud University, Le Kremlin Bicetre, France

    Background/Purpose: Seropositivity for RF or ACPA is associated with a better short-term effectiveness and drug retention of abatacept (ABA) and rituximab (RTX). Data are very…
  • Abstract Number: 585 • 2016 ACR/ARHP Annual Meeting

    Disease Associated Anti-Citrullinated Protein Memory B Cells in Rheumatoid Arthritis Persist in DAS Remission

    Adam J. Pelzek1, Caroline Grönwall2, Lelise Getu3, Pamela Rosenthal4, Jeffrey D. Greenberg5, Mandy J. McGeachy6, Larry W. Moreland7 and Gregg J. Silverman8, 1New York University School of Medicine, New York, NY, 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, New York University School of Medicine, New York, NY, 4Rheumatology, New York University School of Medicine, New York, NY, 5New York University School of Medicine, Millburn, NJ, 6Medicine, University of Pittsburgh, Pittsburgh, PA, 7Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 8Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY

    Background/Purpose: B cells are central drivers of seropositive RA, and B cells that express anti-citrullinated protein antibodies (ACPA) may arise from past and/or ongoing breaches…
  • Abstract Number: 586 • 2016 ACR/ARHP Annual Meeting

    Association Between ACPA Fine Specificity and High Resolution Computed Tomography Lung Changes in Patients with Early Rheumatoid Arthritis

    Vijay Joshua1, Katerina Chatzidionysiou1, Gudrun Reynisdottir1, Aase Hensvold1, Monika Hansson1, Leonor Nogueira2, Guy Serre2, Johan Grunewald3 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM, Toulouse, France, 3Division of Respiratory Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Airways abnormalities that are consistent with inflammation are common in anti-CCP2 positive subjects without inflammatory arthritis. Anti-CCP2 antibodies are associated with high-resolution computed tomography…
  • Abstract Number: 587 • 2016 ACR/ARHP Annual Meeting

    Synovial Immunophenotype and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiological Prognosis

    Carl Orr1, Aurélie Najm2, Monika Biniecka3, Francis Young1, Ursula Fearon4 and Douglas J. Veale1, 1Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 2Rheumatology, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 3St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 4Trinity College Dublin, Department of Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Circulating anti-citrullinated peptide antibodies (ACPA) have been proposed as an important clinical test for stratification of patients presenting with rheumatoid arthritis (RA). ACPA may…
  • Abstract Number: 590 • 2016 ACR/ARHP Annual Meeting

    Microvesicles in the Lungs of Early Rheumatoid Arthritis

    Vijay Joshua1, Fariborz Mobarrez1, Gudrun Reynisdottir1, Johan Öckinger2, Jan Wahlström2, Johan Grunewald2, Heidi Wähämaa1 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Division of Respiratory Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Structural changes, increased tissue citrullination and signs of local inflammation are present in the pulmonary compartment of early seropositive RA and seropositive individuals at…
  • Abstract Number: 1035 • 2016 ACR/ARHP Annual Meeting

    The Prognostic Value of Different Auto-Antibodies for Arthritis Development in Patients with Clinically Suspect Arthralgia

    Robin M ten Brinck1, Hanna W van Steenbergen1, Marije K. Verheul1, Leendert A. Trouw2 and Annette HM van der Helm-van Mil3, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Previous longitudinal studies in arthralgia patients studied Rheumatoid Factor (IgM-RF) and Anti-Citrullinated Protein Antibodies (ACPA) in relation to arthritis development. Participants in these studies…
  • Abstract Number: 6 • 2016 ACR/ARHP Annual Meeting

    Lower Omega-3 Fatty Acid Biomarkers Are Associated with Inflammatory Arthritis in a Population Positive for Anti-Citrullinated Protein Antibodies

    Ryan W. Gan1, Elizabeth A. Bemis1, M. Kristen Demoruelle2, Kevin D. Deane2, Christopher C. Striebich3, James H. Goddard4, Stacey A. Brake4, Michael J. Clare-Salzler5, V. Michael Holers6 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Division of Rhuematology, University of Colorado School of Medicine, Aurora, CO, 4Nine Health Services, Inc., Denver, CO, 5Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, 6Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Antibodies to citrullinated protein antigens (ACPA) can be elevated prior to onset of inflammatory arthritis (IA) and RA. However, understanding of factors related to…
  • Abstract Number: 1108 • 2016 ACR/ARHP Annual Meeting

    Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies

    Akilan Krishnamurthy1, Jimmy Ytterberg2, Meng Sun1, Vijay Joshua1, Heidi Wähämaa1, Nataliya Tarasova2, Khaled Amara1, Johanna Steen1, Vivianne Malmström1, Bence Rethi1 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Immature dendritic cells (DCs) can develop into osteoclasts (OCs), however, the mechanisms regulating this differentiation switch are not yet understood. We have shown that…
  • Abstract Number: 130 • 2016 ACR/ARHP Annual Meeting

    Anti-CCP Status Determines the Power Doppler Oscillation Pattern in Rheumatoid Arthritis – a Prospective Study

    Ottar Gadeholt1, Tobias Wech2, Sebastian Schuh1, Eva Christina Scharbatke1, Eva Niederle1, Hans-Peter Tony3 and Marc Schmalzing4, 1Rheumatology/Immunology, Medical Clinic II, University Clinic Wuerzburg, Wuerzburg, Germany, 2Experimental Rradiology, University Clinic Wuerzburg, Wuerzburg, Germany, 3Rheumatology/Immunology, Medical Clinic II, University Clinic Wuerzburg, Würzburg, Germany, 4Rheumatology/Clinical Immunology, Medical Clinic II, University Clinic Wuerzburg, Würzburg, Germany

    Title: Anti-CCP Status Determines the Power Doppler Oscillation Pattern in Rheumatoid Arthritis – a Prospective Study Abstract: Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology